Prolonged benefit in the treatment of chronic idiopathic urticaria with astemizole

Autor:	R W, Honsinger, R J, Thomsen
Rok vydání:	1990
Předmět:	Clinical Trials as Topic Time Factors Double-Blind Method Urticaria Chronic Disease Histamine H1 Antagonists Humans Benzimidazoles Astemizole
Zdroj:	Annals of allergy. 65(3)
ISSN:	0003-4738
Popis:	A double-blind clinical trial of 51 patients with chronic idiopathic urticaria using oral astemizole for 8 weeks demonstrated significant improvement in symptoms and lesions in 75% of treated patients versus 20% in the placebo group. The suppression of urticaria persisted for an average of 38 days, demonstrating the long duration of action of astemizole.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid________::d6d2aaf6001473d29ef81b147d958eca https://pubmed.ncbi.nlm.nih.gov/1976298 Zobrazit plný text záznamu